Biogen Pharma News - Search Videos

FDA approves first Alzheimer's drug in 18 years

FDA approves first Alzheimer's drug in 18 years

CBS NewsRachel Layne

Biogen halted trial could boost M&A activity, says analyst

Biogen halted trial could boost M&A activity, says analyst

FDA Gives Green Light to Biogen's Alzheimer’s Drug

FDA Gives Green Light to Biogen's Alzheimer’s Drug

Bloomberg.comCristin Flanagan

Biogen CEO Christopher Viehbacher breaks down his outlook for '23

Biogen CEO Christopher Viehbacher breaks down his outlook for '23

Biogen shares fall after Alzheimer's drug approval. Here's what the pros are saying

Biogen shares fall after Alzheimer's drug approval. Here's what the pro…

Biogen Slips As Alzheimer's Drug Looks Abroad For Sales Beat

Biogen Slips As Alzheimer's Drug Looks Abroad For Sales Beat

The $42B Samsung Biogen deal is too cheap, says Oppenheimer Health Care analyst Holz

The $42B Samsung Biogen deal is too cheap, says Oppenheimer Hea…

Company | Biogen

Careers | Biogen

Now is the time for investors to take profits in Biogen, says Jim Cramer

Biogen CEO Sees New Chapter in Fight Against Alzheimer's

Bloomberg.comJohn Tozzi

Here’s Why Biogen Is Forking Over $1.25 Billion to a Small Danish Bio…

FortuneSy Mukherjee

Biogen seeks FDA approval for experimental Alzheimer's drug

ABC NewsErin Schumaker

Biogen to Sell Biosimilar-Venture Stake to Partner Samsung Biologics

Here's what the FDA's endorsement of the Alzheimer's drug Leqembi …

Three Surprising Names That Could Be On Biogen's Buyout Shortlist

Biogen is buying up an immune drug developer for $1.8 billion

FDA approves Biogen Alzheimer’s drug for first time in 18 years

Biogen Takes A Beating After Earnings Report. Here's Why.

Biogen Skids After Winning Alzheimer's Drug Approval

Biogen cuts the price tag on its Alzheimer's drug in half

Biogen stock surges on report of potential acquisition by Samsung …

YahooYahoo Finance Video

Biogen drug: Medicare will pay for controversial Alzheimer’s treatment

NBC NewsBerkeley Lovelace Jr.

Sage Therapeutics Draws Negative Commentary on Biogen Deal

Biogen strikes RNAi deal with City; Aurion withdraws IPO

YahooBioPharma Dive staff

Biogen shares soar on landmark Alzheimer trial results

10.2K viewsSep 28, 2022

YahooReuters Videos

Biogen shares fall on 4Q results but Canaccord analysts remain optimi…

proactiveinvestors.com

Medicare told to reassess premium hike after price slashed on Bioge…

fox2detroit.com

Biogen (NasdaqGS:BIIB) Selects Multiple Co-Lead Underwriters for …

Yahooeditorial-team@simplywallst.com (Simply Wall St)

Biogen Higher as Investors Await FDA Decision on Alzheimer's Drug

See more videos